In PIK3CA-mutant and HER2+ breast cancer cells, PI3K/AKT signaling frequently drives mTORC1, which in turn activates p70S6 kinase (p70S6K) (Supplementary Figure 2). This evidence concerns the gene ERBB2 and breast carcinoma.